本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cartesian Therapeutics

8.19
-0.2400-2.85%
盤後8.190.00000.00%19:30 EDT
成交量:12.31萬
成交額:103.58萬
市值:2.48億
市盈率:-1.41
高:8.88
開:8.59
低:8.18
收:8.43
52周最高:11.00
52周最低:5.60
股本:3,025.54萬
流通股本:1,240.27萬
量比:1.26
換手率:0.99%
股息:- -
股息率:- -
每股收益(TTM):-5.7983
每股收益(LYR):-5.0200
淨資產收益率:-7029.26%
總資產收益率:-17.43%
市淨率:-1.98
市盈率(LYR):-1.63

資料載入中...

2024/11/07

重要事件披露

Form 8-K - Current report
2024/10/15

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/04

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/28

SEC問詢函

Form CORRESP - Correspondence
2024/09/27

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/09/26

重要事件披露

Form 8-K - Current report
2024/09/23

重要事件披露

Form 8-K - Current report
2024/09/21

SEC問詢函

Form CORRESP - Correspondence
2024/09/20

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/09/10

SEC問詢函

Form CORRESP - Correspondence
2024/09/09

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/02

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/07/12

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/05

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/02

重要事件披露

Form 8-K - Current report
2024/06/17

重要事件披露

Form 8-K - Current report
2024/05/22

重要事件披露

Form 8-K - Current report
2024/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]